The EPS projection of InvenSense, Inc. (NYSE:INVN) for quarter ended 2016-09-30 is $-0.05. Last week, the projection for EPS was $-0.05 against target of $-0.05, a month earlier. While 2-months ago, this projection was $-0.05 versus forecast of $-0.05a quarter months earlier, posting a deviation of 0%.
InvenSense, Inc. (NYSE:INVN) posted that 18 days earlier, the share price was revised 0 times on upside. In addition, negative revisions were 2.
In last week, negative EPS revisions were 0 times and positive EPS revisions were 0 times. In last one-month and two month the positive revisions were 0 and 0. While in last 120 and 90 days, positive revisions were 0, and 0, correspondingly.
The per-share earnings downgrade for InvenSense, Inc. (NYSE:INVN) in the preceding 30 and 120 were 0 and 3. While in 60 and 90 days were 0, and 3, in that order.
InvenSense, Inc. (NYSE:INVN) EPS target was $-0.05 for the quarter closed 4. It was based on 4 calls. As on 2016-05-09 the EPS was $-0.08. The change was $-0.01, posting a deviation of -14.29%. The price projections gave a standard deviation of 0.01.
Quarterly Sales Estimates
InvenSense, Inc. (NYSE:INVN) sales prediction for the fiscal 2018 stands at $90.94 and the median estimate is at $91. Almost 3 analysts gave sales target.
Among this, the highest sales estimate is $101.32 while the lowest target is $80.5 showing standard deviation of 10.41%.
As many as 3 analysts have positive sales targets revision while 3 reduced sales estimates, posting a deviation of 0%.
Last month, 3 experts have positive sales number revision. Also, 3 research groups lowered the sales projections, posting a deviation of 0%.
A quarter ago, 3 hiked sales target and 3 reduced sales forecast, posting a deviation of -13.136%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...